Advertisement

Hepatitis B pp 67-93 | Cite as

The Morphologic Expression of Hepatitis B

  • Evgenya Skarinsky
  • Emanuel Rubin

Abstract

There are at least three different viruses responsible for the common varieties of hepatitis: the hepatitis A virus (HAV), the hepatitis B virus (HBV), and an unidentified virus or group of viruses called non-A, non-B (NANB). The symptoms and extent of liver injury produced in acute viral hepatitis vary from a mild, non-icteric, subclinical illness to acute icteric hepatitis, massive necrosis and hepatic failure. It is estimated that 5–10% of adults infected with HBV develop a chronic carrier state, manifested by the presence of the surface antigen (HBsAg) in the blood. The severity and variability of clinical and pathological forms of HB are related to the intensity and virulence of the infection and the quality and quantity of the immune response. Although a role for immune responses in the pathogenesis of hepatic injury is not conclusively proved, the data, such as the consistency of humoral and cellular responses, the presence of abnormal plasma immunoregulatory proteins (rosette inhibitory factor, RIF) (15,16,17), decreased suppressor cell activity (21), and the presence within the liver itself of potent immunosuppressive molecules, are compatible with explanations for recovery, acute and chronic injury, and the carrier state. Following inoculation or ingestion, the virus reaches the liver, where extensive virus replication occurs within the hepatocytes.

Keywords

Viral Hepatitis Primary Biliary Cirrhosis Chronic Active Hepatitis Portal Tract Acute Viral Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anthony, P. P., et al. (1977). The morphology of cirrhosis: definition, nomenclature and classification. Bull. WHO 55:521–540.PubMedGoogle Scholar
  2. 2.
    Anthony, P. P., Vogel, C. L., and Barker, L. F. (1973.) Liver cell dysplasia: a premalignant condition. J. Clin. Pathol. 26:217–223.PubMedCrossRefGoogle Scholar
  3. 3.
    Baggenstoss, A. H., Summerskill, W. H. J., and Ammon, A. V. (1974). The morphology of chronic hepatitis, in The Liver and its Diseases, F. Schaffner, S. Sherlock and C. M. Leevy, eds., Intercontinental Medical Book Corporation, New York, pp. 199–206.Google Scholar
  4. 4.
    Becker, M. D., Scheuer, P. J., Baptista, A., and Sherlock, S. (1970). Prognosis of chronic persistent hepatitis. Lancet 1:53–70.PubMedCrossRefGoogle Scholar
  5. 5.
    Bianchi, L., DeGroote, J., Desmet, V. J., Gedigh, P., Korb, G., Popper, H., Poulsen, H., Scheuer, P. J., Schmid, M., Tahler, H., and Welper, W. (1977). Acute and chronic hepatitis revisited. Lancet 2:914–919.Google Scholar
  6. 6.
    Bjorneboe, M. (1974). Viral hepatitis and cirrhosis. Clin. Gastroenterol. 3:409–418.PubMedGoogle Scholar
  7. 7.
    Blumberg, B. S. and London, W. T. (1980). Hepatitis B virus and primary hepatocellular carcinoma: Relationship of “Icrons” to cancer, in Viruses in Naturally Occurring Cancers, M. Essex, G. Todaro and H. zur Hausen, eds., Cold Spring Harbor Laboratory, New York, pp. 401–421.Google Scholar
  8. 8.
    Boyer, J. L. (1976). Chronic hepatitis. A perspective on classification and determinants of prognosis. Gastroenterology 70:1161–1171.PubMedGoogle Scholar
  9. 9.
    Boyer, J. L. and Klatskin, G. (1970). Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). N. Engl. J. Med. 283:1063–1071.PubMedCrossRefGoogle Scholar
  10. 10.
    Buchanan, T. F., Jr. and Huvos, A. G. (1974). Clear cell carcinoma of the liver. Am. J. Clin. Pathol. 61:529–539.PubMedGoogle Scholar
  11. 11.
    Celle, G., Testa, R., Valpi, O., and Dodero, M. (1980). Morphologic evaluation of CAH with and without therapy. A two year follow-up. Hepato-Gastroent. 27:283–285.Google Scholar
  12. 12.
    Christofferson, P. and Dietrichson, O. (1974). Histological change in liver biopsies from patients with chronic hepatitis. Acta. Path. Microbiol. Scand. (A) 82:539–546.Google Scholar
  13. 13.
    Christofferson, P., Poulsen, H., and Scheuer, P. J. (1972). Abnormal bile duct epithelium in chronic aggressive hepatitis and primary biliary cirrhosis. Human Pathology 3:227–235.CrossRefGoogle Scholar
  14. 14.
    Cook, G. C. and Sherlock, A. (1965). Jaundice and its relation to therapeutic agents. Lancet 1:175–195.PubMedCrossRefGoogle Scholar
  15. 15.
    Chisari, F. V. and Edgington, T. S. (1975). Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein. J. Exp. Med. 142:1092–1107.PubMedCrossRefGoogle Scholar
  16. 16.
    Chisari, F. V., Routenberg, J. A., and Edgington, T. S. (1977). Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infection. J. Clin. Invest. 57:1227–1238.CrossRefGoogle Scholar
  17. 17.
    Chisari, F. V., Routenberg, J. A., Fiala, M., and Edgington, T. S. (1977). Extrinsic modulation of human T-lymphocyte E-rosette function associated with prolonged hepatocellular injury after viral hepatitis, J. Clin. Invest. 59:134–142.PubMedCrossRefGoogle Scholar
  18. 18.
    DeGroote, J., Fevery, J., and Lepoutre, L. (1978). Long term follow-up of chronic active hepatitis of moderate severity. Gut. 19:510–513.CrossRefGoogle Scholar
  19. 19.
    Desmet, V. J. (1972). Chronic hepatitis (including primary biliary cirrhosis). in The Liver, E. A. Gall and F. K. Mostofi, eds., Williams and Wilkins, Baltimore, pp. 286–341.Google Scholar
  20. 20.
    Desmet, V. J. and DeGroote, J. (1974). Histological diagnosis of viral hepatitis. Clin. Gastroenterol. 3:337–354.PubMedGoogle Scholar
  21. 21.
    Edgington, T. S. and Chisari, F. V. (1975). Immunological aspects of hepatitis B virus infection. Am. J. Med. Sci. 270:213–227.CrossRefGoogle Scholar
  22. 22.
    Edmondson, H. A. and Steiner, P. E. (1954). Primary carcinoma of the liver: a study of 100 cases among U.S. 900 necropsies. Cancer 7:462–503.PubMedCrossRefGoogle Scholar
  23. 23.
    Fauerholdt, L., Asnaes, S., Ranek, L., Schigdt, T., and Tygstrup, N. (1977). Significance of suspected “chronic aggressive hepatitis” in acute hepatitis. Gastroenterology 73:639–645.Google Scholar
  24. 24.
    Galambos, J. T. (1964). Chronic persisting hepatitis. Am. J. Dig. Dis. 9:817–831.PubMedCrossRefGoogle Scholar
  25. 25.
    Gerber, M. A. and Thung, S. N. (1979). The localization of hepatitis viruses in tissues. Int. Rev. Exp. Pathol. 2:49–76.Google Scholar
  26. 26.
    Gocke, D. J. (1978). Immune complex phenomena associated with hepatitis, in Viral Hepatitis, G. N. Vyas, S. N. Cohen and R. Schmid, eds., Franklin Institute Press, Philadelphia, pp. 227–283.Google Scholar
  27. 27.
    Gyorkey, F., Melnick, J. L., Mirkovic, R., et al. (1977). Experimental carcinoma of the liver in macague monkeys exposed to diethylnitrosamine and hepatitis B virus. J. Natl. Cancer Inst. 59:1451–1467.PubMedGoogle Scholar
  28. 28.
    Hadizyannis, S. J. (1974). Chronic viral hepatitis. Clin. Gastroenterol. 3:391–408.Google Scholar
  29. 29.
    Hadziyannis, S. J., Vissoulis, C., Moussauros, A., and Afroudakis, A. (1972). Cytoplasmic localization of Australia antigen in the liver. Lancet 1:976–979.PubMedCrossRefGoogle Scholar
  30. 30.
    Hopf, U., Meyer zum Buschenfeld, K. H., and Arnold, W. (1976). Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N. Engl. J. Med. 294:578–582.PubMedCrossRefGoogle Scholar
  31. 31.
    Homey, J. T. and Galambos, J. T. (1977). The liver during and after fulminant hepatitis. Gastroenterology 73:639–645.Google Scholar
  32. 32.
    Huang, S. N. (1975). Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections. Lab. Invest. 33:88–95.PubMedGoogle Scholar
  33. 33.
    Ishak, K. G. (1976). Light microscopic morphology of viral hepatitis. Am. J. Clin. Pathol. 65:787–827, 1976.PubMedGoogle Scholar
  34. 34.
    Ishak, K. G. (1972). Viral hepatitis. The morphologic spectrum, in The Liver, E. A. Gall and F. K. Mostofi, eds., Williams and Wilkins, Baltimore, pp. 218–268.Google Scholar
  35. 35.
    Kaff, R. S. (1978). Viral Hepatitis. Wiley, New York.Google Scholar
  36. 36.
    Karvountzis, G. G., Redeker, A. G., and Peters, R. L. (1974). Long-term follow-up of patients surviving fulminant viral hepatitis. Gastroenterology 67:870–877.PubMedGoogle Scholar
  37. 37.
    Kew, M. C., Ray, M. B., Desmet, V. J., et al. (1980). Hepatitis B surface antigen in tumor tissue and non-tumorous liver in black patients with hepatocellular carcinoma. Br. J. Cancer 40:399–406.CrossRefGoogle Scholar
  38. 38.
    Krugman, S. and Giles, J. P. (1979). Viral hepatitis, type B (MS-2 Strain). Further observations on natural history and prevention. N. Engl. J. Med. 300:101–106.PubMedCrossRefGoogle Scholar
  39. 39.
    Kubo, Y., Okuda, K., Musha, H., et al. (1978). Detection of hepatocellular carcinoma during a clinical follow-up chronic liver disease. Gastroenterology 74:578–582.PubMedGoogle Scholar
  40. 40.
    Lefkowitch, J. H., Arborgh, B. A. M., and Scheuer, P. G. (1980). Oxyphilic granular hepatocytes, mitochondrionrich liver cells in hepatic disease. Am. J. Clin. Pathol. 74:432–441.PubMedGoogle Scholar
  41. 41.
    Lin, J. J. (1970). Primary cancer of the liver. Scand. J. Gastroenterol. 5 (Suppl. 6):223–241.Google Scholar
  42. 42.
    Lin, J. J., Liu, C., and Svoboda, D. J. (1974). Long term effect of aflatoxin B and viral hepatitis on marmoset liver. A preliminary report. Lab. Invest. 30:267–278.Google Scholar
  43. 43.
    MacSween, N. M. R. (1980). Pathology of viral hepatitis and its sequelae. Clin. Gastroenterol. 9:23–45.PubMedGoogle Scholar
  44. 44.
    Maupas, P., Larouze, B., London, W. T., Werner, B., Millman, I., O’Connell, A., Blumberg, B. S., Saimot, G., and Payet, M. (1975). Antibody to hepatitis B core antigen in patients with primary hepatic carcinoma. Lancet 2:9–11.PubMedCrossRefGoogle Scholar
  45. 45.
    Nayak, N. C., Dhar, A., Sachdeva, R., Mittal, A., Seth, H. N., Sudarsanam, O., Reddy, B., Wagholikar, U. L., and Reddy, C. R. R. M. (1977). Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver. Int. J. Cancer 20:643–654.PubMedCrossRefGoogle Scholar
  46. 46.
    Nazarewicz, T., Krawezynski, K., Sluzarczyk, J., et al. (1977). Cellular localization of hepatitis B virus antigens in patients with hepatocellular carcinoma co-existing with liver cirrhosis. J. Infect. Dis. 135:298–302.PubMedCrossRefGoogle Scholar
  47. 47.
    Nielson, J.O., Dietrichson, O., Elling, P., and Christofferson, P. (1971). Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N. Engl. J. Med. 285:1157–1160.CrossRefGoogle Scholar
  48. 48.
    Peters, R. L. (1975). Viral hepatitis: A pathologic spectrum. Am. J. Med. Sci. 270:17–31.PubMedCrossRefGoogle Scholar
  49. 49.
    Peters, R. L., Omata, M., Ashcavai, M., and Liew, C. T. (1978). Protracted viral hepatitis with impaired regeneration, in Viral Hepatitis, G. N. Vyas, S. N. Cohen and R. Schmid, eds., Franklin Institute Press, Philadelphia, pp. 79–84.Google Scholar
  50. 50.
    Peters, R. L. (1976). Pathology of hepatocellular carcinoma, in Hepatocellular Carcinoma, K. Okuda, R. L. Peters, eds., Wiley, New York-London-Sydney-Toronto, pp. 107–168.Google Scholar
  51. 51.
    Phillips, M. J. and Paucell, S. (1981). Modern aspects of the morphology of viral hepatitis. Human Pathology 12:1060–1084.PubMedCrossRefGoogle Scholar
  52. 52.
    Popper, H. (1972). The pathology of viral hepatitis. Can. Med. Assoc. J. 106:447–452.PubMedGoogle Scholar
  53. 53.
    Popper, H., Paronetto, I., and Schaffner, F. (1965). Immune processes in the pathogenesis of liver disease. Ann. N. Y. Acad. Sci. 124:781–799.PubMedCrossRefGoogle Scholar
  54. 54.
    Popper, H. and Udenfriend, S. (1970). Hepatic fibrossis. Am. J. Med. 49:707–721.PubMedCrossRefGoogle Scholar
  55. 55.
    Poulsen, H. and Christofferson, P. (1972). Abnormal bile duct epithelium in chronic aggressive hepatitis and cirrhosis: a review of morphology and clinical, biochemical and immunologie features. Human Pathology 3:217–225.PubMedCrossRefGoogle Scholar
  56. 56.
    Prates, M. D. and Torres, F. D. (1965). A cancer survey in Lourenco Margues, Portugese East Africa. J. Natl. Cancer Inst. 35:729–757.PubMedGoogle Scholar
  57. 57.
    Prince, A. M. (1971). Role of serum hepatitis virus in chronic liver disease. Gastroenterology 60:913–921.PubMedGoogle Scholar
  58. 58.
    Rappaport, A. M. (1969). Anatomic considerations, in Diseases of the Liver, L. Schiff, P.I. J. B. Lippincott, Philadelphia.Google Scholar
  59. 59.
    Redeker, A. G. (1974). Fulminant hepatitis, in The Liver and its Diseases, F. Schaffner, S. Sherlock and C. M. Leevy, eds., Intercontinental Medical Book Corporation, New York, pp. 149–155.Google Scholar
  60. 60.
    Redeker, A. G. (1975). Viral hepatitis: clinical aspects. Am. J. Med. Sci. 270:9–16.PubMedCrossRefGoogle Scholar
  61. 61.
    Robinson, W. S. (1978). Hepatitis B Dane particles DNA structure and the mechanisms of the endogenous DNA polymerase reaction, in Viral Hepatitis, G. N. Vyas, S. N. Cohen and R. Schmid, eds., Franklin Institute Press, Philadelphia, pp. 139–145.Google Scholar
  62. 62.
    Schaffner, F. (1966). Intralobular changes in hepatocytes and the electron microscopic mesenchymae response in acute viral hepatitis. Medicine 45:547–552.PubMedCrossRefGoogle Scholar
  63. 63.
    Scheuer, P. J. (1977). Chronic hepatitis: A problem for the pathologist. Histopathology 1:5–19.PubMedCrossRefGoogle Scholar
  64. 64.
    Schweitzer, T. L., Mosley, J. W., Ashcavai, M., et al. (1973). Factors influencing neonatal infection by hepatitis B virus. Gastroenterology 65:277–283.PubMedGoogle Scholar
  65. 65.
    Schweitzer, T. L., Wing, A., McPeak, C., and Spears, R. L. (1972). Hepatitis and hepatitis-associated antigen in 56 mother-infant pairs. JAMA 220:1092–1095.PubMedCrossRefGoogle Scholar
  66. 66.
    Shikata, T., Yamazaki, S., and Uzawa, T. (1977). Hepatocellular carcinoma and chronic persistent hepatitis. Acta Pathologica Japonica 27:297–304.PubMedGoogle Scholar
  67. 67.
    Shouval, D. Chakraborty, P. R. Ruiz-Opazo, N., Baum, S., Spigland, T., Muchmore, E., Gerber, M. A., and Thung, S. N. (1980). Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic and viral DNA studies. Proc. Natl. Acad. Sci. USA 77:6147–6151.PubMedCrossRefGoogle Scholar
  68. 68.
    Sidi, S., Michel, H., Peters, R. L., and Redeker, A. G. (1974). Chronic persistent hepatitis. A clinicopathological study of 100 cases. Arch. Fr. Mal. App. Dig. 63:285–295.PubMedGoogle Scholar
  69. 69.
    Soloway, R. D., et al. (1972). Clinical, biochemical and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 63:820–833.PubMedGoogle Scholar
  70. 70.
    Tabor, E., Gerety, R. J., Vogel, C. L., Bayley, A. C., Anthony, P. P., Chan, C. H., and Barker, L. F. (1977). Hepatitis B virus infection and primary hepatocellular carcinoma. J. Natl. Cancer Inst. 58:1197–1200.PubMedGoogle Scholar
  71. 71.
    Tisdale, W. A. (1966). Clinical and pathologic features of subacute hepatitis. Medicine 45:557–563.PubMedCrossRefGoogle Scholar
  72. 72.
    Trevisian, A., Realdi, G., Losi, C., et al. (1978). Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissue. J. Clin. Pathol. 31:1133–1139.CrossRefGoogle Scholar
  73. 73.
    Turbitt, M. L., Patrick, R. S., Gouldie, R. B., et al. (1977). Incidence in Southwest Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma. J. Clin. Pathol. 30:1124–1128.PubMedCrossRefGoogle Scholar
  74. 74.
    U.S. Government Printing Office: Diseases of the Liver and Biliary Tract. Standardization of Nomenclature. Diagnostic Criteria, and Diagnostic Methodology. (1976). Washington, Fogarty International Center Proceedings No. 22 DHEW Publication No. (NIH) 76-725. DHEW, Washington, D. C.Google Scholar
  75. 75.
    Wands, J. R., et al. (1975). Cell-mediated immunity in acute and chronic hepatitis. J. Clin. Invest. 55:921–929.PubMedCrossRefGoogle Scholar
  76. 76.
    Wright, R., McCollum, R. W., and Klatskin, G. (1969). Australia antigen in acute and chronic liver disease. Lancet 2:117–121.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Evgenya Skarinsky
    • 1
  • Emanuel Rubin
    • 1
  1. 1.Department of Pathology and Laboratory MedicineHahnemann University School of MedicinePhiladelphiaUSA

Personalised recommendations